Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

Science prevails. Doc Williams has done the studies. Science has shown with clear, real, undeniable data that his compound/drugs outperformed the best Big Pharma has to offer. Better than that, NMDA-antagonists modulate the immune response. They decrease neuronal hyperexcitability and prevent cell death. They alter the endothelial permeability and will decrease acute lung injury and ARDS. More than a one trick pony. Multiple trials ahead. Even though I am ALL FOR THE SCIENCE. The one thing nobody can deny... the FDA invited them to submit for a trial. What more could we ask for.